Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097331
Status:
COMPLETED
Last Update Posted:
2015-04-13
First Post:
2004-11-22
Brief Title:
Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
None
Primary Completion Date:
2006-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-07
Completion Date Type:
ACTUAL
First Submit Date:
2004-11-22
First Submit QC Date:
November 22 2004
Study First Post Date:
2004-11-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-10
Last Update Post Date:
2015-04-13
Last Update Post Date Type:
ESTIMATED